SCRYB Insider Trading
CSE NP
2
All Trades
1
Significant
1
Notable
2
Clusters
0
Repeat
Financial Services
Sector
Asset Management
Industry
$5.6M
Market Cap
0.09 – 0.15
52 Week Range
146K
Avg. Volume
| Company | Insider | Title | Date | Shares | Price | Value | Balance | Increase | Signal |
|---|---|---|---|---|---|---|---|---|---|
| SCRYB | Van Staveren, Gregory | CEO | 29-Jan-26 | 601,000 | SI CL | ||||
| SCRYB | Van Staveren, James | CEO | 29-Jan-26 | 1,354,500 | NT CL |
SCRYB (NP): Insider trading △ Insider buy
Volume (thousands)
Related Companies to Explore
Company Info
Company Description: SCRYB
SCRYB is a company listed on the Canadian Securities Exchange under the ticker CSE:SCYB. Based on the company name and typical sector positioning, SCRYB operates in the biotechnology or life sciences space, likely focusing on innovative research, diagnostics, or therapeutic development. The company is incorporated in Canada and maintains operations within the Canadian market while potentially serving international clients and partners.
As a publicly traded entity on the CSE, SCRYB is subject to Canadian securities regulations and reporting requirements. The company operates within the competitive landscape of Canadian biotech and life sciences firms, positioning itself to attract institutional and retail investors interested in emerging healthcare technologies. Like other CSE-listed companies, SCRYB’s operational focus and commercial activities are disclosed through regular filings with Canadian securities authorities. Investors seeking detailed information about the company’s specific products, revenue streams, partnerships, and financial performance are advised to consult official regulatory filings, investor relations materials, and current company announcements available through CSE databases and the company’s official channels.
Don’t miss today’s trades
Full access to real-time insider buying data — $8.25/mo, billed annually. Cancel anytime.
